Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
amgen
5
×
boston blog main
boston top stories
deals
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
gene therapy
medicare
merck
pfizer
startups
abbvie
alnylam pharmaceuticals
alzheimer's
alzheimer's disease
astrazeneca
What
bio
roundup
drug
acquisitions
biggest
ceo
company
moves
patients
terms
acquire
agreed
albert
alzheimer’s
becker
billion
billions
bourla
brings
build
buy
cash
cholesterol
company’s
compound
congress
crispr
daniel
deal
debut
democrats
divided
dollars
dyne’s
eaton
elections
fallout
fda
future
gene
Language
unset
unknown
Current search:
novartis
×
amgen
×
deals
×
photo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel